Clinical trial
Alendronate for Vascular Calcification in Peritoneal Dialysis Patients?
NCT00299572 · Far Eastern Memorial Hospital, Other · Unknown status
Key facts
| NCT number | NCT00299572 |
|---|---|
| Title | Alendronate for Vascular Calcification in Peritoneal Dialysis Patients? |
| Official title | Can Alendronate Suppress Aortic and Coronary Artery Calcification and Improve Bone Mineral Density in Chronic Peritoneal Dialysis Patients? |
| Lead sponsor | Far Eastern Memorial Hospital, Other |
| Status | Unknown status |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Peritoneal Dialysis |
| Intervention type | Drug |
| Interventions | alendronate (Fosamax) |
| Enrollment | 50 |
| Start date | Mar 1, 2006 |
| Completion | Dec 1, 2006 |
| First posted | Mar 7, 2006 |
| Last update posted | Mar 7, 2006 |
| Countries | Taiwan |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: